Clinical Updates & Insights

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

233 Clinical Updates found
Scientific image
Clinical Update
Chemotherapy after immune checkpoint inhibitors (ICIs) may improve survival rates in patients with heavily pretreated, recurrent ovarian cancer.
Patient talking to medical professionals
Clinical Update
Cytoreductive surgery for advanced ovarian cancer is safe in older women, even those who present with frailty.
Ira Dunkel
Clinical Update
Decreasing values for apparent diffusion coefficient (ADC) mapping derived from MRI may indicate the development of trilateral retinoblastoma in pediatric patients with bilateral retinoblastoma.
Colorectal Liver
Clinical Update
The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels. However, questions remain about the effectiveness of its use in patients with initially unresectable colorectal liver metastases.
Nai-Kong Cheung, MD, PhD
Clinical Update
High-risk neuroblastoma cells harbor distinguishing molecular signatures, according to recent research.
oligodendroglioma
Clinical Update
Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy.
Dr. Anthony F. Yu and patient
Clinical Update
In our recently published review paper we provide a comprehensive update on the cardiotoxicities associated with contemporary breast cancer treatment and the latest strategies for their prevention, detection, and management.
radiation therapy
Clinical Update
Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.
surgeons operating on patient
Clinical Update
New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research.
Radiation Oncologist,  Suzanne Wolden with child patient
Clinical Update
Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial.